Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA4B9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,460
Award facts
- Contract value 100% obligated
- $27,460.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials with a ceiling value of $27,460.15 under a firm fixed-price contract structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of January 30, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under the parent company Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This task order exemplifies AmerisourceBergen's critical role in supplying pharmaceutical products to military healthcare systems and the Defense Health Agency. The award of Ozempic, a diabetes medication, reflects the company's comprehensive portfolio spanning specialty medications, brand-name and generic drugs, and other therapeutic domains essential to military treatment facilities and federal healthcare programs. As a major pharmaceutical distributor operating through open competition, AmerisourceBergen continues to demonstrate its capability to efficiently fulfill government contracts for essential medical commodities supporting military readiness and veteran healthcare initiatives worldwide.
Quick answers
Who was awarded contract SPE2DR26FA4B9?
SPE2DR26FA4B9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FA4B9 worth?
The government has obligated $27,460 on SPE2DR26FA4B9.
Is contract SPE2DR26FA4B9 an order under another contract?
Yes. SPE2DR26FA4B9 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA4B9 competed?
The extent of competition for SPE2DR26FA4B9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award